New Hope for Parkinson's: Ceftriaxone Shows Promise in Treatment

New drugs for Parkinson's disease?

Hello Dr.
Jiang: Recently, I came across information online stating that a team led by Professor He Ying-Rui from Chung Shan Medical University has spent 10 years researching and discovered that the antibiotic ceftriaxone, used for treating meningitis, may help inhibit brain cell damage in patients with Parkinson's disease, potentially allowing for healing of tremors and rigidity.
This is the first discovery of its kind globally, and patents have been obtained in mainland China and the United States.
It is expected to be used in clinical treatment after passing human trials.
They also mentioned that it is more effective in early-stage patients.
I am very interested in trying this; what are your thoughts, Dr.
Yang? Thank you, Dr.
Jiang!

Hung, 50~59 year old female. Ask Date: 2016/05/03

Dr. Jiang Junyi reply Neurology

Hello, according to your description, Professor He’s article "Ceftriaxone prevents the neurodegeneration and decreased neurogenesis seen in a Parkinson’s disease rat model: An immunohistochemical and MRI study" was published in "Behavioural Brain Research" in May 2016.
The main research focuses on the toxin-induced rat model of Parkinson’s disease (PD) using 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Currently, there are many clinical medications available for Parkinson’s disease patients to alleviate symptoms, but patients with brain injuries caused by synthetic opioids like MPT are less common.
We look forward to further research from Professor He’s team addressing related issues in general patients.
I suggest consulting a neurologist (movement disorder specialist) for discussion, examination, and treatment.
Wishing you good health, safety, and happiness.

Reply Date: 2016/05/03

More Info

The research you mentioned regarding ceftriaxone and its potential benefits for Parkinson's disease is indeed intriguing and represents a significant step forward in the exploration of new treatment avenues for this challenging condition. Parkinson's disease is a progressive neurodegenerative disorder characterized by motor symptoms such as tremors, rigidity, and bradykinesia, as well as non-motor symptoms that can severely impact quality of life. Current treatments primarily focus on managing symptoms, particularly through dopaminergic medications like levodopa, but they do not halt disease progression.

Ceftriaxone, a broad-spectrum cephalosporin antibiotic traditionally used to treat bacterial infections, has been studied for its neuroprotective properties. The research you referenced suggests that ceftriaxone may help to protect neurons in the brain from damage associated with Parkinson's disease. This is particularly relevant because one of the hallmarks of Parkinson's is the degeneration of dopaminergic neurons in the substantia nigra, a critical area of the brain involved in movement control.

The mechanism by which ceftriaxone exerts its neuroprotective effects appears to involve the modulation of glutamate levels in the brain. Glutamate is a neurotransmitter that, in excessive amounts, can lead to excitotoxicity and neuronal death. Ceftriaxone has been shown to increase the expression of a specific glutamate transporter, GLT-1, which helps to clear excess glutamate from the synaptic cleft, thereby reducing the risk of excitotoxic damage.

While the findings from the research team led by Professor He Ying-Rui are promising, it is essential to approach this news with cautious optimism. The transition from laboratory findings to clinical application involves several critical steps, including rigorous clinical trials to assess the safety and efficacy of ceftriaxone in Parkinson's patients. These trials will help determine the appropriate dosing, potential side effects, and the specific patient populations that may benefit most from this treatment.

It is also worth noting that while initial studies may show promise, the effectiveness of ceftriaxone may vary among individuals, and it may not be suitable for all patients with Parkinson's disease. Factors such as the stage of the disease, overall health, and the presence of comorbid conditions will play a significant role in treatment decisions.

If you are considering participating in clinical trials or exploring this treatment option, it is crucial to discuss it with your healthcare provider. They can provide personalized advice based on your specific medical history and condition. Additionally, they can help you stay informed about the latest research developments and guide you in making informed decisions regarding your treatment plan.

In conclusion, while ceftriaxone shows promise as a potential treatment for Parkinson's disease, further research is necessary to validate its efficacy and safety in humans. As always, maintaining open communication with your healthcare team is vital as you navigate your treatment options.

Similar Q&A

Can Parkinson's Disease Be Cured? Exploring Alternatives to Medication

Currently, there is no cure for Parkinson's disease. In addition to medication, there are several other approaches that may help manage symptoms. These include physical therapy, occupational therapy, and speech therapy, which can improve mobility, daily functioning, and comm...

Dr. Lin Zijing reply Neurology
Parkinson's disease is a chronic central nervous system disorder, with its etiology hypothesized to be related to the rapid degeneration of dopaminergic neurons in the substantia nigra, leading to insufficient production of the neurotransmitter dopamine and enhanced choliner...

Breakthroughs in Parkinson's and Essential Tremor Treatment: Rehabilitation Insights

Hello Director: There have been significant breakthroughs in surgical treatment for Parkinson's disease and essential tremor. National Taiwan University Hospital and Chang Gung Memorial Hospital have both announced successful cases of deep brain electrode implantation for th...

Dr. Chen Xianchang reply Rehabilitation
(1) Deep brain stimulation for Parkinson's disease has shown good results, often more effective than medication. (2) Risks include potential infections, seizures, and hemorrhagic strokes. (3) Rehabilitation involves applying heat therapy, electrical stimulation, and exercise...

Understanding Creutzfeldt-Jakob Disease: Current Treatments and Research Updates

Dr. Chen: Hello, I heard that you are an expert in researching Creutzfeldt-Jakob disease (CJD). My father has been ill since the end of February this year, and it has been five months. He was previously treated at your hospital and is currently in a nursing home, unconscious and ...

Dr. Chen Shunsheng reply Rare Disease
A potential new treatment for Creutzfeldt-Jakob Disease (CJD) has finally been discovered. CJD and human transmissible spongiform encephalopathies are both fatal conditions and currently classified as untreatable rare diseases. A research group led by Nobel laureate Prusiner at t...

Managing Parkinson's Disease: Medication Challenges and Control Strategies

Hello Doctor: I was diagnosed with Parkinson's disease this August. Currently, I am experiencing frequent and significant tremors in my left foot, and during severe episodes, my big toe tends to curl inward. Additionally, I have muscle soreness in my buttocks and my feet swe...

Dr. Hong Weibin reply Neurology
Hello: The tremors associated with Parkinson's disease are mostly resting tremors, which can typically be temporarily controlled by willpower or by maintaining a tense posture (such as raising the legs). However, once the individual relaxes, the tremors reappear, which is re...